Your Messages Inbox
Your Article Summary
See Latest ArticlesMedtronic-Supported Clinical Trial Shows ICD Patients Less Likely to Develop Need for Pacing When Device Uses MVP Mode
Medtronic, 05/18/09
MVP, exclusive programming on Medtronic pacemakers, which is proven to be effective in reducing unnecessary pacing in pacemaker patients, was applied in the MVP Trial of implantable cardioverter-defibrillator patients. Data from MVP trial, sponsored by Medtronic, Inc, were presented today as a late breaking clinical trial at Heart Rhythm 2009, the annual scientific sessions of the Heart Rhythm Society.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/09/09
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
Trials, 12/09/09
Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/09/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Genentech, 12/08/09
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Article Search
Sponsor